SCHEMBL6281898

SCHEMBL6281898

O=C(O)c1ccc(C(=O)N2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)c2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.41
NR4A1 P22736 1/20 0.38
NR4A2 P43354 1/20 0.38
NR4A3 Q92570 1/20 0.38
ALDH1A1 P00352 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
POLB P06746 1/20 0.37
APOBEC3A P31941 1/20 0.37
RECQL P46063 1/20 0.37
CASP6 P55212 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MTHFD2 P13995 1/20 0.37
MMP3 P08254 1/20 0.36
MMP8 P22894 1/20 0.36
WDR5 P61964 1/20 0.36
LDHA P00338 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15463104 0.74 TDP1 (0.40) KDM4EALDH1A1L3MBTL1POLBRECQL
SCHEMBL15463106 0.71 ATM (0.42) KMT2AMEN1ADRA1B
SCHEMBL28798 0.71 NR4A1 (0.65) KDM4ENR4A1NR4A2NR4A3ALDH1A1
SCHEMBL30838413 0.71 NR4A1 (0.65) KDM4ENR4A1NR4A2NR4A3ALDH1A1
SCHEMBL30838412 0.71 NR4A1 (0.65) KDM4ENR4A1NR4A2NR4A3ALDH1A1
SCHEMBL29406630 0.71 NR4A1 (0.65) KDM4ENR4A1NR4A2NR4A3ALDH1A1
Bromide SCHEMBL21173947 0.69 NR4A1 (0.62) KDM4ENR4A1NR4A2NR4A3ALDH1A1
Fluoride SCHEMBL21331927 0.69 NR4A1 (0.62) KDM4ENR4A1NR4A2NR4A3ALDH1A1
SCHEMBL7738797 0.69 NR4A1 (0.62) KDM4ENR4A1NR4A2NR4A3ALDH1A1
SCHEMBL31436579 0.69 NR4A1 (0.62) KDM4ENR4A1NR4A2NR4A3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6919365-B2 Imidazolidinedione derivatives and use thereof as drugs SENJU PHARMACEUTICAL CO., LTD. (JP) 2005-07-19 US disclosed
US-20040110811-A1 Novel imidazolidinedione derivatives and use thereof as drugs SENJU PHARMACEUTICAL CO., LTD. (JP) 2004-06-10 US disclosed
EP-1384715-A1 NOVEL IMIDAZOLIDINEDIONE DERIVATIVES AND USE THEREOF AS DRUGS Senju Pharmaceutical Co., Ltd. (JP) 2004-01-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110811-A1 Novel imidazolidinedione derivatives and use thereof as drugs CMA1, TPSD1, TPSB2 KDM4E 1696/4885NR4A1 30/4885NR4A2 49/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.